Alterity Therapeutics Ltd.
Important Dates
Alterity Therapeutics Limited's next confirmed earnings release is scheduled for March 4, 2027.
| Earnings Date | 3/4/2027 |
Share Statistics
As of June 30, 2026, Alterity Therapeutics Limited has 217.51M shares outstanding.
| Shares Outstanding | 217.51M |
Financial Position
As of June 30, 2026, Alterity Therapeutics Limited maintains a current ratio of 14.52, meaning it holds 14.5x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 14.52 |
| Quick Ratio | 14.26 |
| Debt / Equity | 0.45 |
Financial Efficiency
These figures cover the twelve months ended June 30, 2026.
| Employee Count | 9.50 |
Stock Price Statistics
USDAs of the close on October 12, 2026, Alterity Therapeutics Limited's stock has declined approximately 28.57% over the past 52 weeks. The 50-day moving average sits at 0.39, while the 200-day moving average is 1.04.
| 52-Week Price Change | -28.57% |
| 50-Day Moving Average | 0.39 |
| 200-Day Moving Average | 1.04 |
Balance Sheet
USDAs of June 30, 2026, Alterity Therapeutics Limited holds 25.83M in cash and equivalents against 133,885.81 in total debt, resulting in a net debt position of -25.83M. Total book value stands at 29.57M, with working capital of 29.53M providing operational flexibility.
| Cash & Cash Equivalents | 25.83M |
| Total Debt | 133,885.81 |
| Net Debt | -25.83M |
| Equity (Book Value) | 29.57M |
| Book Value Per Share | 0.14 |
| Working Capital | 29.53M |
Stock Splits
Alterity Therapeutics Limited's most recent stock split took place on June 3, 2026 with a 50:1 split ratio.
| Last Split Date | 6/3/2026 |
| Split Ratio | 50:1 |